百濟神州(06160)向兩名主要股東合計增發1.458億股 淨籌160.4億港元
百濟神州(06160)發佈公告,於2020年7月12日,公司與該等買方訂立該協議,該公司向該等買方發行1.458億股購買股份,購買價為每股購買股份14.2308美元(約110.29港元)(相當於每股美國存托股份185美元)。
購買股份的數目相當於認購事項完成後經擴大已發行股份總數約12.54%。購買價較2020年7月10日在聯交所所報的收市價每股股份119.30港元折讓約7.6%。
據悉,截至該公告日期,兩名買方(即Baker Bros. Advisors LP及Amgen Inc.)連同彼等的聯屬實體為公司的主要股東,並因此為公司關聯人士。
所得款項淨額(經扣除所有適用成本及開支後)將約為20.7億美元(約160.4億港元)。用作營運資金及其他一般公司用途,包括:
(a) 資助公司研究及臨床開發活動(包括擴展其批准產品的適應症),推進其管線產品(包括內部開發分子及授權許可化合物),以及發展及擴展其臨床前項目;
(b)推進業務開發活動,以通過授權許可或收購(如適用)新增技術、藥物或候選藥物、腫瘤學領域內外其他資產或業務擴展公司的商業及開發階段產品組合或其他戰略投資或機會;
(c) 投資公司批准產品於中國、美國以及其他可能地區市場的商業活動;
(d) 擴展並進一步建立公司在商業化、製造以及研發等領域的全球組織及能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.